Healthcare provider profile · identity verified

Amanda K Domingus, APRN

Nurse Practitioner · RUTLAND, VT · NPI 1881209328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	220	68
Levothyroxine Sodium	Levothyroxine Sodium	216	47
Pantoprazole Sodium	Pantoprazole Sodium	166	32
Simvastatin	Simvastatin	144	39
Omeprazole	Omeprazole	140	44
Amlodipine Besylate	Amlodipine Besylate	126	34
Lisinopril	Lisinopril	116	37
Losartan Potassium	Losartan Potassium	114	33
Gabapentin	Gabapentin	108	26
Albuterol Sulfate Hfa	Albuterol Sulfate	98	46
Metoprolol Succinate	Metoprolol Succinate	91	21
Trazodone Hcl	Trazodone Hcl	91	23
Sertraline Hcl	Sertraline Hcl	80	19
Famotidine	Famotidine	78	16
Rosuvastatin Calcium	Rosuvastatin Calcium	74	23
Alendronate Sodium	Alendronate Sodium	67	16
Duloxetine Hcl	Duloxetine Hcl	63	23
Hydrochlorothiazide	Hydrochlorothiazide	63	15
Olmesartan Medoxomil	Olmesartan Medoxomil	60	20
Metformin Hcl	Metformin Hcl	53	16
Doxycycline Hyclate	Doxycycline Hyclate	50	44
Prednisone	Prednisone	50	35
Metoprolol Tartrate	Metoprolol Tartrate	47	12
Tamsulosin Hcl	Tamsulosin Hcl	47	14
Potassium Chloride	Potassium Chloride	46	15
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Furosemide	Furosemide	45	13
Donepezil Hcl	Donepezil Hcl	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	23
Pravastatin Sodium	Pravastatin Sodium	41	11
Ozempic	Semaglutide	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Cephalexin	Cephalexin	38	32
Eliquis	Apixaban	37	11
Methylprednisolone	Methylprednisolone	37	34
Metformin Hcl Er	Metformin Hcl	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Spironolactone	Spironolactone	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Torsemide	Torsemide	28	11
Bupropion Xl	Bupropion Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	12
Levetiracetam	Levetiracetam	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Atenolol	Atenolol	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Carvedilol	Carvedilol	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Finasteride	Finasteride	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Methimazole	Methimazole	16	suppressed
Risperidone	Risperidone	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ramipril	Ramipril	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Folic Acid	Folic Acid	14	suppressed
Nystatin	Nystatin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	12
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Moxifloxacin Hcl	Moxifloxacin Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error